Karachi August 14 2024: BF Biosciences Limited, a subsidiary of Ferozsons Laboratories Limited, has successfully introduced human insulin under the brand name “Ferulin.”.
Share price of Ferozsons Laboratories Limited (FEROZ) hit upper limit at Pakistan Stock Exchange after the announcement.
BF Biosciences Limited (BFBL) has applied for listing on the main board of the Pakistan Stock Exchange (PSX), seeking to raise a minimum of PKR 1.37 billion by selling 25 million shares to institutional, high net worth, and individual investors, pending regulatory approval.
“This launch represents a key achievement in our ongoing efforts to combat diabetes, broaden our product offerings, and improve access to essential medications in the market” states the company.
The company added, “Developed with the highest quality standards, Ferulin aims to provide effective and affordable diabetes care to patients throughout Pakistan.”
As Pakistan’s first biotech plant, BF Biosciences Limited has been dedicated for over a decade to producing vital medicines for the treatment of HCV, cancer, cardiovascular conditions, and other therapeutic areas. We believe that Ferulin will significantly contribute to the growth of our subsidiary and further strengthen our mission to meet unmet patient needs.
